FDA Imaging Endpoint Guidance Tells Sponsors To Charter "Incidental Findings"
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry is wary of any mandate to report incidental findings to patients and their doctors, worried that it may be “inappropriately delegating a new responsibility to practice medicine by sponsors.” Firms press the agency to revise draft document.